Comparative Analysis of Short-Term and Long-Term Clinical Efficacy of Mesenchymal Stem Cells from Different Sources in Knee Osteoarthritis: A Network Meta-Analysis.

Although the differences between treatment modalities did not reach statistical significance, BMMSCs may exhibit a slight advantage over other sources of MSCs (BMMSC vs. the PRP (MD = 0, 95% CI −19.29, to 18.99), HA (MD = −1.06, 95% CI −22.3 to 13.51), ADMSC (MD = −0.5, 95% CI −26.05 to 18.61), UCMSC (MD = −1.03, 95% CI −30.44 to 21.69)) ( Table 2 ) ( Figure 4(d) ).

also in 111,027 other papers